Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,646 | 209 | 97.7% |
| Education | $110.23 | 3 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,557 | 70 | $0 (2024) |
| Janssen Biotech, Inc. | $345.85 | 13 | $0 (2024) |
| ABBVIE INC. | $282.54 | 16 | $0 (2024) |
| Boston Scientific Corporation | $264.15 | 5 | $0 (2024) |
| COLOPLAST CORP | $200.06 | 8 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $178.41 | 8 | $0 (2024) |
| PFIZER INC. | $140.45 | 8 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $137.81 | 9 | $0 (2022) |
| Myriad Genetic Laboratories, Inc. | $123.55 | 4 | $0 (2024) |
| Teleflex LLC | $121.29 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $719.99 | 29 | ACCORD HEALTHCARE, INC. ($107.81) |
| 2023 | $922.70 | 34 | Astellas Pharma US Inc ($353.71) |
| 2022 | $600.28 | 31 | Astellas Pharma US Inc ($144.01) |
| 2021 | $686.54 | 31 | Astellas Pharma US Inc ($156.33) |
| 2020 | $200.32 | 10 | Astellas Pharma US Inc ($64.86) |
| 2019 | $517.39 | 26 | Astellas Pharma US Inc ($211.88) |
| 2018 | $568.80 | 30 | Astellas Pharma US Inc ($394.88) |
| 2017 | $540.63 | 21 | Astellas Pharma US Inc ($156.88) |
All Payment Transactions
212 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $13.18 | General |
| 12/05/2024 | Axonics, Inc. | Bulkamid (Device) | Food and Beverage | In-kind items and services | $45.47 | General |
| Category: Urology | ||||||
| 11/25/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Oncology | ||||||
| 10/24/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: ONCOLOGY | ||||||
| 09/10/2024 | Becton, Dickinson and Company | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Urology | ||||||
| 08/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: UROLOGY | ||||||
| 08/27/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Oncology | ||||||
| 08/13/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/31/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/25/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $16.33 | General |
| Category: ONCOLOGY | ||||||
| 05/24/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: rezum_URO | ||||||
| 05/22/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Oncology | ||||||
| 05/07/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Oncology | ||||||
| 04/27/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/24/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $64.85 | General |
| Category: Oncology | ||||||
| 04/18/2024 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Urology | ||||||
| 04/16/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Oncology | ||||||
| 04/09/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: ONCOLOGY | ||||||
| 03/28/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $25.94 | General |
| 03/22/2024 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Urology | ||||||
| 03/15/2024 | COLOPLAST CORP | Luja Coude (Device) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Continence Care | ||||||
| 03/05/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/29/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $36.73 | General |
| Category: UROTHELIAL CANCER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,685 | 15,238 | $692,993 | $187,885 |
| 2022 | 34 | 3,180 | 21,077 | $745,223 | $205,684 |
| 2021 | 30 | 3,219 | 25,875 | $798,707 | $217,518 |
| 2020 | 28 | 3,010 | 23,028 | $661,782 | $171,401 |
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 513 | 755 | $150,263 | $66,984 | 44.6% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 22 | 165 | $31,110 | $21,897 | 70.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 165 | 194 | $82,838 | $10,939 | 13.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 102 | 102 | $29,274 | $10,836 | 37.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 169 | 179 | $24,344 | $10,447 | 42.9% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 20 | 23 | $80,300 | $10,064 | 12.5% |
| 76100 | X-ray of body plane | Office | 2023 | 109 | 142 | $39,760 | $9,319 | 23.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 44 | $11,440 | $5,962 | 52.1% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 62 | 64 | $23,232 | $5,264 | 22.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 451 | 616 | $41,272 | $4,895 | 11.9% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2023 | 34 | 39 | $23,400 | $4,593 | 19.6% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 36 | 88 | $26,928 | $4,223 | 15.7% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 641 | 937 | $15,929 | $3,632 | 22.8% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 12 | 1,150 | $6,900 | $2,597 | 37.6% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 17 | 31 | $9,362 | $2,227 | 23.8% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 16 | 39 | $10,725 | $2,195 | 20.5% |
| 51705 | Simple change of bladder tube | Office | 2023 | 20 | 32 | $10,624 | $2,050 | 19.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 20 | 23 | $19,177 | $1,816 | 9.5% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 18 | 18 | $7,110 | $1,643 | 23.1% |
| 76705 | Limited ultrasound scan of abdomen | Office | 2023 | 23 | 23 | $7,176 | $1,635 | 22.8% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 15 | 16 | $11,952 | $1,582 | 13.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 22 | $1,782 | $832.70 | 46.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 51 | $2,295 | $484.68 | 21.1% |
| 51701 | Insertion of temporary bladder tube | Office | 2023 | 15 | 15 | $2,925 | $458.04 | 15.7% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 15 | 17 | $1,700 | $441.84 | 26.0% |
About Dr. Brian Cox, MD
Dr. Brian Cox, MD is a Urology healthcare provider based in Yakima, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215034111.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Cox, MD has received a total of $4,757 in payments from pharmaceutical and medical device companies, with $719.99 received in 2024. These payments were reported across 212 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($4,646).
As a Medicare-enrolled provider, Cox has provided services to 12,094 Medicare beneficiaries, totaling 85,218 services with total Medicare billing of $782,488. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Yakima, WA
- Active Since 09/20/2006
- Last Updated 05/20/2014
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1215034111
Products in Payments
- XTANDI (Drug) $814.56
- Myrbetriq (Drug) $434.20
- Xtandi (Drug) $295.32
- ERLEADA (Drug) $248.77
- MYRBETRIQ (Drug) $166.32
- GEMTESA (Drug) $157.51
- GENERAL - ERECTILE DYSFUNCTION (Device) $145.00
- XIAFLEX (Biological) $137.81
- ORGOVYX (Drug) $128.10
- UROLIFT (Device) $121.29
- LUPRON DEPOT (Drug) $121.17
- CAMCEVI (Drug) $107.81
- PROVENGE (Drug) $97.52
- PROLARIS (Device) $94.40
- Lupron Depot (Drug) $93.55
- ELIGARD (Drug) $85.51
- Erleada (Drug) $84.95
- Bulkamid (Device) $83.73
- JELMYTO (Drug) $81.08
- INTERSTIM (Device) $66.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Yakima
Dr. Matthew Uhlman, M.d, M.D
Urology — Payments: $16,340
Eric Lauer, Md, MD
Urology — Payments: $6,043
Dennis Gaskill, M.d, M.D
Urology — Payments: $5,630
Daniel Thorner, D.o, D.O
Urology — Payments: $4,919
Mark Uhlman, M.d, M.D
Urology — Payments: $2,381
Raymond Merrell, M.d, M.D
Urology — Payments: $640.26